BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34214498)

  • 1. Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection.
    Mukherjee R; Bhattacharya A; Bojkova D; Mehdipour AR; Shin D; Khan KS; Hei-Yin Cheung H; Wong KB; Ng WL; Cinatl J; Geurink PP; van der Heden van Noort GJ; Rajalingam K; Ciesek S; Hummer G; Dikic I
    J Biol Chem; 2021 Aug; 297(2):100925. PubMed ID: 34214498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famotidine Repurposing for Novel Corona Virus Disease of 2019: A Systematic Review.
    Chenchula S; Ray A; Sadasivam B
    Drug Res (Stuttg); 2021 Jul; 71(6):295-301. PubMed ID: 33757133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine receptors and COVID-19.
    Ennis M; Tiligada K
    Inflamm Res; 2021 Jan; 70(1):67-75. PubMed ID: 33206207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication.
    Loffredo M; Lucero H; Chen DY; O'Connell A; Bergqvist S; Munawar A; Bandara A; De Graef S; Weeks SD; Douam F; Saeed M; Munawar AH
    Sci Rep; 2021 Mar; 11(1):5433. PubMed ID: 33686143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients.
    Hogan Ii RB; Hogan Iii RB; Cannon T; Rappai M; Studdard J; Paul D; Dooley TP
    Pulm Pharmacol Ther; 2020 Aug; 63():101942. PubMed ID: 32871242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus rhamnosus Restores Antiviral Signaling and Attenuates Cytokines Secretion from Human Bronchial Epithelial Cells Exposed to Cigarette Smoke and Infected with SARS-CoV-2.
    Olímpio F; Andreata-Santos R; Rosa PC; Santos W; Oliveira C; Aimbire F
    Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1513-1528. PubMed ID: 36346611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.
    Yang H; George SJ; Thompson DA; Silverman HA; Tsaava T; Tynan A; Pavlov VA; Chang EH; Andersson U; Brines M; Chavan SS; Tracey KJ
    Mol Med; 2022 May; 28(1):57. PubMed ID: 35578169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
    Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
    mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
    Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
    Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
    Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
    J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production.
    So EY; Kim BS
    Glia; 2009 Aug; 57(11):1216-26. PubMed ID: 19191335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.
    Li K; Li NL; Wei D; Pfeffer SR; Fan M; Pfeffer LM
    Hepatology; 2012 Mar; 55(3):666-75. PubMed ID: 22030901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-histamines and Covid-19: Hype or Hope.
    Al-Kuraishy HM; Al-Rubiey HF; Al-Buhadily AK; Al-Gareeb AI
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S144-S148. PubMed ID: 35130238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3.
    Zhang W; Ma Z; Wu Y; Shi X; Zhang Y; Zhang M; Zhang M; Wang L; Liu W
    Cytokine; 2021 Dec; 148():155697. PubMed ID: 34509038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Status of Famotidine in COVID-19 Patients: A Review.
    Mohseni M; Raissi V; Sharifan Y; Barikro K; Amiri S; Mohseni MS; Raeisi F; Masoumi K; Khodakarami S; Raiesi O
    Infect Disord Drug Targets; 2022; 22(3):e070122200096. PubMed ID: 34994318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
    Shin D; Mukherjee R; Grewe D; Bojkova D; Baek K; Bhattacharya A; Schulz L; Widera M; Mehdipour AR; Tascher G; Geurink PP; Wilhelm A; van der Heden van Noort GJ; Ovaa H; Müller S; Knobeloch KP; Rajalingam K; Schulman BA; Cinatl J; Hummer G; Ciesek S; Dikic I
    Nature; 2020 Nov; 587(7835):657-662. PubMed ID: 32726803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis.
    Ortega JT; Serrano ML; Jastrzebska B
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19.
    Ishola AA; Joshi T; Abdulai SI; Tijjani H; Pundir H; Chandra S
    J Biomol Struct Dyn; 2022 Aug; 40(13):5785-5802. PubMed ID: 33491579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.